Paul Tudor Jones Intellia Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 47,475 shares of NTLA stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
47,475Holding current value
$1.06 Million% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding NTLA
# of Institutions
313Shares Held
89.3MCall Options Held
686KPut Options Held
599K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$246 Million2.16% of portfolio
-
Black Rock Inc. New York, NY9.11MShares$204 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$204 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$103 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.21MShares$94.2 Million3.83% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.7B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...